KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Net Margin (2016 - 2025)

Astrana Health (ASTH) has disclosed Net Margin for 16 consecutive years, with 0.69% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 186.0% to 0.69% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.76% through Dec 2025, down 170.0% year-over-year, with the annual reading at 0.76% for FY2025, 170.0% down from the prior year.
  • Net Margin hit 0.69% in Q4 2025 for Astrana Health, up from 0.11% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 30.2% in Q2 2021 to a low of 9.3% in Q4 2021.
  • Historically, Net Margin has averaged 3.48% across 5 years, with a median of 3.83% in 2023.
  • Biggest YoY gain for Net Margin was 984bps in 2022; the steepest drop was -2602bps in 2022.
  • Year by year, Net Margin stood at 9.3% in 2021, then soared by 97bps to 0.3% in 2022, then tumbled by -1083bps to 3.55% in 2023, then soared by 67bps to 1.17% in 2024, then skyrocketed by 159bps to 0.69% in 2025.
  • Business Quant data shows Net Margin for ASTH at 0.69% in Q4 2025, 0.11% in Q3 2025, and 1.56% in Q2 2025.